Trial
NCT04648696
Safety and Outcomes Associated With Continuous Versus Intermittent Infusion Vancomycin
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Infection
Intervention
Vancomycin CI
Why stopped
The study was closed due to slow enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-14